Literature DB >> 28678138

PharmGKB summary: pazopanib pathway, pharmacokinetics.

Caroline F Thorn1, Manish R Sharma, Russ B Altman, Teri E Klein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28678138      PMCID： PMC5862561          DOI： 10.1097/FPC.0000000000000292

Source DB:  PubMed          Journal:  Pharmacogenet Genomics        ISSN： 1744-6872            Impact factor:   2.089


× No keyword cloud information.
  41 in total

1.  Hyperbilirubinemia in pazopanib- or sunitinib-treated patients in COMPARZ is associated with UGT1A1 polymorphisms.

Authors:  R J Motzer; T Johnson; T K Choueiri; K C Deen; Z Xue; L N Pandite; C Carpenter; C F Xu
Journal:  Ann Oncol       Date:  2013-10-09       Impact factor: 32.976

Review 2.  Genetic contribution to variable human CYP3A-mediated metabolism.

Authors:  Jatinder K Lamba; Yvonne S Lin; Erin G Schuetz; Kenneth E Thummel
Journal:  Adv Drug Deliv Rev       Date:  2002-11-18       Impact factor: 15.470

3.  Interleukin-8: A potent promoter of angiogenesis in gastric cancer.

Authors:  Jun Shi; Pin-Kang Wei
Journal:  Oncol Lett       Date:  2015-12-15       Impact factor: 2.967

4.  Association of the hemochromatosis gene with pazopanib-induced transaminase elevation in renal cell carcinoma.

Authors:  Chun-Fang Xu; Brian H Reck; Vicki L Goodman; Zhengyu Xue; Lingkang Huang; Michael R Barnes; Beena Koshy; Colin F Spraggs; Vincent E Mooser; Lon R Cardon; Lini N Pandite
Journal:  J Hepatol       Date:  2011-02-12       Impact factor: 25.083

Review 5.  Vascular endothelial growth factor pathway.

Authors:  Michael L Maitland; Xing Jian Lou; Jacqueline Ramirez; Apurva A Desai; Dorit S Berlin; Howard L McLeod; Ralph R Weichselbaum; Mark J Ratain; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2010-05       Impact factor: 2.089

6.  Increased in vivo transcription of an IL-8 haplotype associated with respiratory syncytial virus disease-susceptibility.

Authors:  D Hacking; J C Knight; K Rockett; H Brown; J Frampton; D P Kwiatkowski; J Hull; I A Udalova
Journal:  Genes Immun       Date:  2004-06       Impact factor: 2.676

7.  Association of IL-8-251A/T polymorphism with incidence of Acute Respiratory Distress Syndrome (ARDS) and IL-8 synthesis after multiple trauma.

Authors:  Frank Hildebrand; Manfred Stuhrmann; Martijn van Griensven; Sven Meier; Sandra Hasenkamp; Christian Krettek; Hans-Christoph Pape
Journal:  Cytokine       Date:  2007-05-10       Impact factor: 3.861

8.  Pharmacokinetic-pharmacodynamic correlation from mouse to human with pazopanib, a multikinase angiogenesis inhibitor with potent antitumor and antiangiogenic activity.

Authors:  Rakesh Kumar; Victoria B Knick; Sharon K Rudolph; Jennifer H Johnson; Renae M Crosby; Ming-Chih Crouthamel; Teresa M Hopper; Charles G Miller; Laura E Harrington; James A Onori; Robert J Mullin; Tona M Gilmer; Anne T Truesdale; Andrea H Epperly; Amogh Boloor; Jeffrey A Stafford; Deirdre K Luttrell; Mui Cheung
Journal:  Mol Cancer Ther       Date:  2007-07       Impact factor: 6.261

9.  HLA-B*57:01 Confers Susceptibility to Pazopanib-Associated Liver Injury in Patients with Cancer.

Authors:  Chun-Fang Xu; Toby Johnson; Xiaojing Wang; Chris Carpenter; Alan P Graves; Liling Warren; Zhengyu Xue; Karen S King; Dana J Fraser; Sandy Stinnett; Linda P Briley; Ionel Mitrica; Colin F Spraggs; Matthew R Nelson; Hiroomi Tada; Andreas du Bois; Thomas Powles; Neil Kaplowitz; Lini N Pandite
Journal:  Clin Cancer Res       Date:  2015-11-06       Impact factor: 12.531

10.  Haplotypes in IL-8 Gene Are Associated to Age-Related Macular Degeneration: A Case-Control Study.

Authors:  Federico Ricci; Giovanni Staurenghi; Tiziana Lepre; Filippo Missiroli; Stefania Zampatti; Raffaella Cascella; Paola Borgiani; Luigi Tonino Marsella; Chiara Maria Eandi; Andrea Cusumano; Giuseppe Novelli; Emiliano Giardina
Journal:  PLoS One       Date:  2013-06-19       Impact factor: 3.240
View more
  2 in total

1.  Pazopanib with low fat meal (PALM) in advanced renal cell carcinoma.

Authors:  Melissa A Reimers; Maryann M Shango; Stephanie Daignault-Newton; Rachel Dedinsky; Danielle Karsies; Shawna Kraft; Liam Riddle; Jeremy A Felton; Bo Wen; Christina Gersch; James M Rae; Bruce G Redman; Ajjai S Alva
Journal:  Invest New Drugs       Date:  2018-11-05       Impact factor: 3.850

Review 2.  CYP3A4∗22 Genotyping in Clinical Practice: Ready for Implementation?

Authors:  Tessa A M Mulder; Ruben A G van Eerden; Mirjam de With; Laure Elens; Dennis A Hesselink; Maja Matic; Sander Bins; Ron H J Mathijssen; Ron H N van Schaik
Journal:  Front Genet       Date:  2021-07-08       Impact factor: 4.599
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.